Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Desmopressin

Troy S. McCarty  1 , Preeti Patel
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Desmopressin

Troy S. McCarty et al.
Free Books & Documents

Excerpt

Desmopressin is a drug that acts on the vasopressin receptors of the body. It has many relevant clinical uses, ranging from nocturnal enuresis to hemophilia. While this drug is relatively safe to use, there are certain side effects to be kept in mind for patients receiving the drug, as well as specific contraindications that limit the population that can receive desmopressin. This activity reviews the indications, mechanism of action, contraindications, and adverse effects. It will also explore the proper monitoring of patients on desmopressin and the role of the inter-professional team required to enhance the outcomes for the patients taking the drug.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Troy McCarty declares no relevant financial relationships with ineligible companies.

Disclosure: Preeti Patel declares no relevant financial relationships with ineligible companies.

References

    1. Ozgönenel B, Rajpurkar M, Lusher JM. How do you treat bleeding disorders with desmopressin? Postgrad Med J. 2007 Mar;83(977):159-63. - PMC - PubMed
    1. Fein S, Herschkowitz S. Low-Dose Desmopressin Nasal Spray and FDA Approval. JAMA. 2017 Sep 19;318(11):1070-1071. - PubMed
    1. Wiśniewski K, Qi S, Kraus J, Ly B, Srinivasan K, Tariga H, Croston G, La E, Wiśniewska H, Ortiz C, Laporte R, Rivière PJ, Neyer G, Hargrove DM, Schteingart CD. Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists. J Med Chem. 2019 May 23;62(10):4991-5005. - PubMed
    1. Desmopressin (Nocdurna and Noctiva) for nocturnal polyuria. Med Lett Drugs Ther. 2019 Mar 25;61(1568):46-48. - PubMed
    1. Konkle BA, Nakaya Fletcher S. Hemophilia A. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet] University of Washington, Seattle; Seattle (WA): 2000. Sep 21, - PubMed

Publication types

LinkOut - more resources